Menu Back toPromotional-and-Misleading-Trial-Results-Summaries-Lay-Summaries-Addressing-the-Elephant-in-the-Room

DIA 2018 Global Annual Meeting


Best Practices for Implementing Lay Summaries and Communicating Results to Patients

    Session Chair(s)
      Behtash  Bahador

      Behtash Bahador

      • Senior Manager, Quality and Compliance
      • CISCRP, United States
    Chief concerns from regulators and patient/public/advocate communicates are that trial results summaries (lay language summaries) are non-promotional, unbiased and not misleading. This session presents case studies and reviews strategies to address these concerns in lay summary content including: narrative content, visual content, process and policy and review.
    Learning Objective : Discuss the importance of and coming requirement for describing clinical trial results for the lay audience. Propose methods to address the requirements and discuss specific issues related to writing for a lay audience.
    Speaker(s)
      Barry  Drees, PhD

      Preparing for the Clinical Trial Report Lay Summary

      Barry Drees, PhD

      • Senior Partner
      • Trilogy Writing & Consulting, Germany
      Paulo  Moreira

      Beyond Lay Summaries: A Vision for Comprehensive Post-Trial Communications

      Paulo Moreira

      • Vice President, Global Clinical Operations, Head of External Innovation
      • EMD Serono, Inc., United States
      Behtash  Bahador

      Promotional and Misleading Lay Summaries: Addressing the Elephant in the Room

      Behtash Bahador

      • Senior Manager, Quality and Compliance
      • CISCRP, United States